Cannabix Technologies Inc. (BLOZF)
| Previous Close | 0.3350 |
| Open | 0.3472 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.3133 - 0.3600 |
| 52 Week Range | 0.1200 - 0.4800 |
| Volume | |
| Avg. Volume | 147,080 |
| Market Cap | 37.095M |
| Beta (5Y Monthly) | 2.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Jul 29, 2024 - Aug 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that it has commenced discussions with Breathalyser Sales & Service Pty Ltd. of Sydney,
- Baystreet
Cannabix, Methanex, Tricon at 52-Week Highs on News
Cannabix Technologies (C.BLO) hit a new 52-week high of 57 cents Thursday. Cannabix Technologies reports ...
GlobeNewswireCannabix’s Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement, employers and other organizations tools to enhance public safetyVANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) a private monitoring agency, ba
